Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024

ROCKVILLIE, Md. and SUZHOU, China, March 7, 2024 /PRNewswire/ — Innovent Biologics, Inc.…

HKBN Enterprise Solutions Becomes Hong Kong's First Certified Alibaba Cloud Landing Zone Partner

HONG KONG, March 7, 2024 /PRNewswire/ — HKBN Enterprise Solutions (HKBNES), a…

MWC2024: Huawei Releases Scenario-Specific Solutions for Retail Industry

BARCELONA, Spain, March 7, 2024 /PRNewswire/ — At MWC Barcelona 2024, Huawei…

Lianlian Global Triumphs with Prestigious Payment Platform Award at Hong Kong Leaders' Choice 2024

Recognized for Outstanding Service and Dedication to Hong Kong’s Financial Ecosystem by…

Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

Reshaping the landscape for the second-line treatments of Small Cell Lung Cancer…

Flyability launches revolutionary UTM payload for Elios 3 drone in Asia Pacific

SINGAPORE, March 7, 2024 /PRNewswire/ — Flyability, the market leader in confined…

A Global Milestone in Innovative Pancreatic Cancer Therapy

Suppression of pancreatic cancer and increased survival rates in animals implanted with…

Elitery Introduces Elipedia, an AI-Based Knowledge Management System, Powered by Google Cloud's Enterprise-Ready Generative AI

JAKARTA, Indonesia, March 6, 2024 /PRNewswire/ — Elitery, a leading IT managed services…